Premier : Coalition Says Transparency, Value-Based Pay Could Contain Drug Costs
April 26, 2016 at 12:10 pm EDT
Share
Modern Healthcare: Increased transparency and competition in the pharmaceutical industry and expanded value-based payment models would help address rising prescription drug prices, according to a coalition aimed at containing costs.
The Campaign for Sustainable Rx Pricing said multiple organizations representing doctors, nurses, hospitals, insurers and consumers have endorsed the proposals to fix what they say is a broken market for prescription drugs. Premier COO Michael Alkire said the group purchasing organization supports the proposal.
Full story
Premier Inc. issued this content on 25 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 26 April 2016 16:09:59 UTC
Original Document: https://www.premierinc.com/coalition-says-transparency-value-based-pay-contain-drug-costs/
Premier, Inc. is a healthcare improvement company uniting an alliance of approximately 4,350 United States hospitals and health systems and approximately 300,000 other providers and organizations. It operates through two segments: Supply Chain Services and Performance Services. The Supply Chain Services segment includes the Companyâs group purchasing organizations (GPO), supply chain co-management, purchased services, and direct sourcing activities. The Performance Services segment consists of three sub-brands, which include PINC AI, the Companyâs technology and services platform; Contigo Health, the Companyâs direct-to-employer business; and Remitra, the Companyâs digital invoicing and payables business. It delivers technology-enabled platform that offers critical supply chain services, clinical, financial, operational and value-based care software as a service (SaaS) as well as clinical and enterprise analytics licenses, consulting services, and third-party administrator services.
PREMIER, INC. 
